Rivaroxaban CAS 366789-02-8 Purity >99.5% (HPLC) Factory API Kounga Teitei

Whakaahuatanga Poto:

Ingoa matū: Rivaroxaban

CAS: 366789-02-8

Maamaa: >99.5% (HPLC)

Te ahua: Paura ma, tata ma ranei

API Kounga Teitei, Hanganga Aromoni

E-Mail: alvin@ruifuchem.com


Taipitopito Hua

Hua e Pa ana

Tohu Hua

Whakaahuatanga:

Nga Ahuatanga matū:

Ingoa matū Rivaroxaban
Nga kupu taurite (S)-Rivaroxaban;(S)-5-Chloro-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)-oxazolidin-5-yl)methyl)thiophene-2-carbox;BAY 59-7939
Tau CAS 366789-02-8
Tūnga Taonga I roto i te Stock, Production Tauine Up ki Taranata
Tātai rāpoi C19H18ClN3O5S
Taumaha rāpoi 435.88
Waitohu Ruifu Chemical

Whakatakotoranga:

Tūemi Whakatakotoranga
Te ahua Paura ma, tata ma ranei
Tautuhi A Ko te whakaurunga infrared o Rivaroxaban e rite ana ki nga paerewa tohutoro
Tautuhinga B Ko te wa pupuri o te tihi matua o te otinga tauira e rite ana ki tera o te otinga pai o te punaha, i riro mai i te purea enantiomeric.
Enantiomeric Pure RVX RC01: ≤0.15%
makuku (KF) ≤0.50%
Te pungarehu whanariki ≤0.10%
Nga Korewa Taamaha ≤20ppm
Waikawa Acetic ≤5000ppm
Matū Paatahi (HPLC)
RVX RC02 ≤0.15%
RVX RC03 ≤0.15%
RVX RC04 ≤0.15%
RVX RC05 ≤0.15%
RVX RC06 ≤0.15%
RVX RC07 ≤0.15%
RVX RC08 ≤0.15%
Tetahi atu poke takitahi ≤0.10%
Nga poke katoa <0.50%
Wairewa Toenga (GC)
Ewaro ≤5000ppm
Toluene ≤890ppm
Triethylamine ≤320ppm
Te Maama / Tikanga Tatauria >99.5% (HPLC) (i runga i te waikore)
Paerewa Whakamatau Paerewa hinonga
Whakamahinga API;Ta'auau Antithrombotic;FXa Inhibitor

Mōkī me te Rokiroki:

Mōkī: Pounamu, Peeke konumohe konumohe, 25kg / Cardboard Drum, kia rite ranei ki te hiahia a te kaihoko.

Tikanga Rokiroki:Whakaorangia i roto i nga ipu kua hiri ki te waahi makariri me te maroke;Tiaki i te marama me te makuku.

Painga:

1

FAQ:

Taupānga:

Rivaroxaban(CAS:366789-02-8) (Xarelto, Bayer) he anticoagulant waha.He aukati tika Xa a-waha.Ko te Rivaroxaban e tohuhia ana mo te 'maimoatanga o te thrombosis vein hohonu me te embolism pulmonary, me te aukati i te thrombosis uaua hohonu me te embolism pulmonary i roto i nga pakeke'.Mo te maimoatanga tuatahi o te pulmonary embolism whakapeka, ko te horopeta o te rivaroxaban he 15 mg e rua nga ra ia ra mo nga ra tuatahi 21 ka whai i te 20 mg kotahi ia ra mo te maimoatanga tonu me te aukati i te thromboembolism venous recurrent.Non-Valvular Atrial Fibrillation (NVAF) ki te aukati i te whiu me te embolism pūnaha.Te maimoatanga VTE whakapeka me te aukati i te VTE auau [mo te thrombosis uaua hohonu (DVT) me te pulmonary embolism (PE)].Te aukati i nga kaupapa thromboembolic venous (VTE) i roto i te kowhiringa katoa o te hip, te pokanga whakakapi turi ranei (THR, TKR).

Tuhia to korero ki konei ka tukuna mai ki a matou